<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>Addition of the mammalian target of rapamycin inhibitor, everolimus, to consolidation therapy in acute myeloid leukemia: experience from the UK NCRI AML17 trial</article-title>
</title-group>
